Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment - aid...

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment  aidsmap

HIV Patients Fare Well with Mpox Treatment - Weill Cornell Medicine Newsroom

HIV Patients Fare Well with Mpox Treatment  Weill Cornell Medicine Newsroom

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls  World Health Organization

UVA Health Effort Aims to Improve HIV Care Across America - UVA Health Newsroom

UVA Health Effort Aims to Improve HIV Care Across America  UVA Health Newsroom

Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir - UN News

Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir  UN News

Monthly HIV injection could free patients from gruelling drug regimen - Nature.com

Monthly HIV injection could free patients from gruelling drug regimen  Nature.com

HIV positive sperm bank launched in New Zealand - News-Medical.Net

HIV positive sperm bank launched in New Zealand  News-Medical.Net

A Potential Cure for AIDS: Defeating HIV With a Single Injection - SciTechDaily

A Potential Cure for AIDS: Defeating HIV With a Single Injection  SciTechDaily

Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds - Livescien...

Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds  Livescience.com

Gilead’s HIV prevention treatment found 100% effective in late-stage trial - MarketWatch

Gilead’s HIV prevention treatment found 100% effective in late-stage trial  MarketWatch

Some children who start antiretrovirals very early may control HIV after stopping treatment - aid...

Some children who start antiretrovirals very early may control HIV after stopping treatment  aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected - aidsmap

So far, Poland has seen fewer Ukrainian refugees with HIV than expected  aidsmap

What are the roles of TAF and integrase inhibitors in weight gain? - aidsmap

What are the roles of TAF and integrase inhibitors in weight gain?  aidsmap

Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey  aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV - aidsmap

After viral rebound, dolutegravir-based treatment more likely to suppress HIV  aidsmap

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds  aidsmap

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy  aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective - aidsmap

Further evidence that recycling tenofovir in second-line treatment is effective  aidsmap

Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries  aidsmap

London patient in long-term HIV remission after stem cell transplant - aidsmap

London patient in long-term HIV remission after stem cell transplant  aidsmap

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - aid...

Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries  aidsmap

Islatravir plus doravirine remains effective at 96 weeks - aidsmap

Islatravir plus doravirine remains effective at 96 weeks  aidsmap

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options - FierceP...

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options  FiercePharma

Reduced-drug treatment becoming common in Paris - aidsmap

Reduced-drug treatment becoming common in Paris  aidsmap

HIV infections lowered by 30% in universal testing and treatment study - aidsmap

HIV infections lowered by 30% in universal testing and treatment study  aidsmap

Are CD4 counts still useful in the 'treat all' era? - aidsmap

Are CD4 counts still useful in the 'treat all' era?  aidsmap

More options for second-line treatment in children shown to be safe and effective - aidsmap

More options for second-line treatment in children shown to be safe and effective  aidsmap

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day - Quartz

How an Indian tycoon fought Big Pharma to sell AIDS drugs for $1 a day  Quartz

Dolutegravir recommended for all in new World Health Organization guidelines - aidsmap

Dolutegravir recommended for all in new World Health Organization guidelines  aidsmap

Genetically engineered white blood cells could be the future of HIV treatment - The Verge

Genetically engineered white blood cells could be the future of HIV treatment  The Verge

Myanmar on brink of HIV treatment crisis - Frontier Myanmar

Myanmar on brink of HIV treatment crisis  Frontier Myanmar

Health ministry approves Truvada as HIV prevention drug - The Japan Times

Health ministry approves Truvada as HIV prevention drug  The Japan Times

Why I injected myself with an untested gene therapy - BBC

Why I injected myself with an untested gene therapy  BBC

Antidepressants improve ART adherence and quality of life in HIV-positive men with depression (Ma...

Antidepressants improve ART adherence and quality of life in HIV-positive men with depression (Mandarin)  aidsmap

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin)  aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - aidsmap

Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin)  aidsmap